According to Reuters, the new Amgen leukemia drug being released today will cost about $178,000, spread over two $89,000 treatment cycles. The price tag will place the drug amongst the world’s most expensive cancer drugs. Blincyto will be used to combat acute lymphoblastic leukemia. Currently, the approval extends to patients who did not respond to previous treatment, or whose cancer has returned. 32 percent of patients in a clinical trial experienced seven months of complete remission after four weeks of receiving the drug.